Northpoint Life Sciences is a Canadian private life sciences company whose focus is the development of technologies for remote monitoring of respiratory conditions. The company was founded by Dr. Jonathan Toma, a Canadian Interventional Cardiologist with an extensive background in medical imaging research, and Dr. Arthur Sung, an Interventional Pulmonologist at the Stanford University School of Medicine, with significant experience working with companies in the Silicon Valley area using electronic sensors and AI-based algorithms to predict respiratory disease progression. Drs. Toma and Sung share a common vision of improving the scope and quality of remote diagnostics for the assessment of chronic lung conditions; a challenge that remains poorly addressed in healthcare services to date. They believe that a fundamental shift towards decentralized healthcare services for care of patients with chronic respiratory illnesses is necessary a step to adequately address this large-scale healthcare burden..
Northpoint is developing both clinical and consumer-grade medical devices to track detailed respiratory physiology information, paired with AI-powered algorithms, to predict disease progression and alert patients and their care providers of changes in their health status. As a mission, we seek to fundamentally improve the landscape of outpatient respiratory care for patients, regardless of their home geography, using state-of-the-art advances in health monitoring technologies and fulfilling the potential of advanced remote connectivity
Northpoint is looking for R&D partners with experience in remote telehealth infrastructure and setup, cloud infrastructure, network data transfer and design, edge computing, cellular network connectivity and connected devices, and IoT integration into hospital networks.